Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report

BACKGROUND: Despite their broadly recommended use as chemotherapeutic agents, the porphyrogenicity of methotrexate and actinomycin D have not been confirmed. Accordingly, it is not known whether these agents are safe for use in patients with porphyria. CASE PRESENTATION: In this report, we present a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikami, Yukiko, Nagai, Tomonori, Gomi, Yousuke, Takai, Yasushi, Saito, Masahiro, Baba, Kazunori, Seki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717627/
https://www.ncbi.nlm.nih.gov/pubmed/26781485
http://dx.doi.org/10.1186/s13256-015-0790-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717627/
https://www.ncbi.nlm.nih.gov/pubmed/26781485
http://dx.doi.org/10.1186/s13256-015-0790-6

Ejemplares similares